Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Capstone Holding Corp.
CAPS
NASDAQ·Basic Materials·Construction Materials·Mkt cap $1.5M
$0.26
▼ -4.74%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$0.23 - $2.07
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 82.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary peptide technology platform
- Novel mechanism of action for Apo E mimetics
- Clinical validation through Phase Ib/IIa trials
- Focused strategy addressing underserved patient populations
Bear Case
1 risk
- Low volatility (beta -1.5).
Growth
Turning profitable
Advancement of AEM-28 through clinical development pipeline
Value
Deep value opportunity - significant discount to Construction Materials peers
Momentum
Falling
-52.6% over 3m
Quality
Stable
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying CAPS right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Aug 13, 2026
MAY 28, 2026
Reported EPS of -$2.68 vs -$0.13 consensus (-1961.5% surprise). Revenue of $12.5M vs $12.5M expected (-0.3%).
EPS surprise · last 4Q
0 of 2 beats
Q2 26
-1961.5%
Q2 26
-10.5%
Next: Aug 13, 2026
Revenue trend · last 8Q
—
—
—
-16%
-0%
+11%
+21%
+60%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$12.9M
$12.3M
$10.3M
$7.9M
$12.9M
$13.7M
$12.5M
$12.6M
Margins · last 8Q
Gross
—
Operating
—
Profit
-15.2%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
No analyst coverage on file for this stock yet.